Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More
Trade Brains
OCTOBER 6, 2023
It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. As per IQVIA report, the global medicine market is expected to reach USD 1.9 Future Plans Cipla Cipla is looking to shift focus towards biosimilars, mRNAs, and (CAR)-T cell therapy. Reddy's - Debt to Equity 0.28 billion patients.
Let's personalize your content